Speaker illustration

Professor Sergiy Koval

L.T.Malaya Therapy National Institute of the NAMS of Ukraine, Kharkiv (Ukraine)

Circulating microRNA-133a and its associations with left ventricular hypertrophy in men with arterial hypertension

Event: ESC Congress 2021 - The Digital Experience

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Session: Hypertension e-posters

Thumbnail

The onset of paroxysmal non-valvular atrial fibrillation in men with hypertension is associated with an increase in blood levels of transforming growth factor beta 1

Event: EHRA 2021

Topic: Pathophysiology and Mechanisms, Other

Session: Pathophysiology of atrial fibrillation and beyond II

Thumbnail

An increase in blood levels of vascular endothelial growth factor and highly sensitive C-reactive protein in patients with hypertension and obesity is associated with the left ventricular hypertrophy

Event: ESC Preventive Cardiology 2021

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Session: ePosters

Thumbnail

Fixed dose combination of olmesartan and amlodipine in patients with hypertension and abdominal obesity. Data of 3-month observation of efficacy and adherence to therapy

Event: ESC Preventive Cardiology 2021

Topic: Pharmacotherapy

Session: ePosters

Thumbnail

24-hour blood pressure monitoring in hypertensive patients with abdominal obesity in the dynamics of antihypertensive treatment

Event: ESC Preventive Cardiology 2021

Topic: Treatment, Other

Session: ePosters

Thumbnail

The associations of circulating microRNA-133a with parameters of hypertension heart disease in patients with arterial hypertension and obesity

Event: ESC Congress 2020

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Session: Hypertension ePosters

Thumbnail